Laura Lee Sandler - 16 Mar 2026 Form 4 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
Chief Operating Officer
Signature
/s/ Paul Quinlan, as attorney-in-fact for Laura Sandler
Issuer symbol
ORKA
Transactions as of
16 Mar 2026
Net transactions value
-$24,780
Form type
4
Filing time
17 Mar 2026, 16:08:09 UTC
Previous filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sandler Laura Lee Chief Operating Officer C/O ORUKA THERAPEUTICS, INC., 855 OAK GROVE AVE., SUITE 100, MENLO PARK /s/ Paul Quinlan, as attorney-in-fact for Laura Sandler 17 Mar 2026 0002075401

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORKA Common Stock Sale $24,780 -600 -0.25% $41.30 236,984 16 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.